The 21st CPHI China Shanghai exhibition was successfully held. CHU PHARMA focused on the Middle East's essential pharmaceutical market, highlighting its sterile injectable APIs and oral formulation contract manufacturing services. The company connected with multiple local pharmaceutical distributors and formulation manufacturers in Saudi Arabia, the UAE, and Iraq on-site. Following the exhibition, CHU PHARMA secured established distributors in Jeddah, Saudi Arabia, and Kuwait, achieving a breakthrough in the Middle East market and further expanding its overseas sales footprint.